IDXG
INTERPACE BIOSCIENCES NEWstockOTC
EODNov 18, 2026
5.435USD-9.417%(-0.565)2,310
IDXG Financials
In Q3 FY 2026 (ended ), INTERPACE BIOSCIENCES NEW (IDXG) reported revenue of $10.37M, net income of −$1.61M, operating cash flow of $970K, and assets of $37.47M (filed ).
Loading business breakdowns…
